NCT02974907: A trial that was reported late by ReGenTree, LLC
This trial has reported, although it was 401 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02974907 |
|---|---|
| Title | A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solutions for the Treatment of Dry Eye : ARISE-2 |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2016 |
| Completion date | Sept. 30, 2017 |
| Required reporting date | Sept. 30, 2020, midnight |
| Actual reporting date | Nov. 5, 2021 |
| Date last checked at ClinicalTrials.gov | March 2, 2026 |
| Days late | 401 |